ライフサイエンスコーパス: cell-penetrating peptide

1 f coupled together with Tat basic peptide, a cell-penetrating peptide.

2 riticale microspores with the help of a Tat2 cell-penetrating peptide.

3 cell culture was demonstrated by fusion to a cell-penetrating peptide.

4 nterfere with the delivery properties of the cell-penetrating peptide.

5 ide conjugates containing oligoarginine as a cell-penetrating peptide.

6 g antisense oligonucleotides conjugated to a cell-penetrating peptide.

7 ewed, followed by analyzing pros and cons of cell penetrating peptides.

8 s of cargo inside mammalian cells similar to cell-penetrating peptides.

9 ny formation relative to electroporation and cell-penetrating peptides.

10 e-rich peptides are among the most effective cell-penetrating peptides.

11 lar uptake and intracellular distribution of cell-penetrating peptides.

12 the absorption of pH-responsive peptides and cell-penetrating peptides.

13 nding and exhibited rapid motions similar to cell-penetrating peptides.

14 aminophenylalanine containing derivatives of cell-penetrating peptides.

15 structural features of cationic amphipathic cell-penetrating peptides.

16 high-throughput screening of the efficacy of cell-penetrating peptides.

17 or investigating the direct translocation of cell-penetrating peptides.

18 localized to tumors by targeted activatable cell-penetrating peptides.

19 11)) and mPCI (Arg(1)-Ala(18)) functioned as cell-penetrating peptides.

20 , ion binding in solution, and activation of cell-penetrating peptides.

21 imeric nanoparticles coated with activatable cell penetrating peptides (ACPPs), labeled with Cy5, gad

22 We recently developed activatable cell-penetrating peptides (ACPPs) that target contrast a

23 lize tumors during surgery using activatable cell-penetrating peptides (ACPPs), in which the fluoresc

24 Unlike the cationic cell-penetrating peptides, alpha-helical antennapedia-li

25 The helix 5 peptide fused to a cell-penetrating peptide also activated endogenous lysos

26 eable protein toxin gelonin via the aid of a cell-penetrating peptide (also termed as protein transdu

27 he in vivo utility of technologies employing cell penetrating peptides and bioportides may be comprom

28 Selected peptide linkers were conjugated to cell penetrating peptides and d-peptide cargoes.

29 linear peptidyl ligands through fusion to a cell-penetrating peptide and cyclization of the fusion p

30 H2O2 through release of the highly adhesive cell-penetrating peptide and disruption of fluorescence

31 aining cleavable linker between polycationic cell-penetrating peptide and polyanionic fragments.

32 s limitation, we test an arginine-rich Pip6a cell-penetrating peptide and show that Pip6a-conjugated

33 oparticles bearing phage display peptides or cell-penetrating peptides and expand the receptor repert

34 in labelled oligonucleotides with a range of cell-penetrating peptides and investigate their abilitie

35 sed to study the noncovalent interactions of cell-penetrating peptides and lipid membranes.

36 Cell-penetrating peptides and proteins (CPPs) are import

37 HDMs has a predicted structural analogy with cell-penetrating peptides and that both the entire prote

38 pproach for studying endocytic mechanisms of cell-penetrating peptides and their effects on cellular

39 t the DSS domain of DPP functions as a novel cell-penetrating peptide, and these findings demonstrate

40 ed to be applicable to other MAPs, including cell-penetrating peptides, and could provide a framework

41 protamine substitute as well as a non-toxic cell penetrating peptide applicable to achieve intracell

42 Cell-penetrating peptides are widely used to deliver car

43 lian nuclear localization sequences and many cell penetrating peptides as molecular sleds.

44 y is enhanced by the action of targeting and cell-penetrating peptides attached to the calcium silica

45 heptapeptide (MSP) fused to an arginine-rich cell-penetrating peptide (B-peptide) and conjugated to a

46 TAT-RasGAP(317-326) is a cell-penetrating peptide-based construct with anticancer

47 Our novel tumor cell-penetrating peptide-based probe (TPP) recognizes an

48 ompared to a PNA705 conjugate with a leading cell-penetrating peptide being developed for therapeutic

49 n efficiently enter cells without the use of cell-penetrating peptides, bind miR-21, its designated m

50 inib in the human CML cell line K562 using a cell-penetrating peptide biosensor and multiple reaction

51 the SAM domain into macrophages via the TAT cell-penetrating peptide blocks proinflammatory cytokine

52 yme to human stem cells through high-density cell penetrating peptide brush polymers.

53 ilizing indocyanine green (ICG) labeled with cell-penetrating peptide carrying a tumor-targeting moti

54 ytic enzyme MMP-2, the probe, an activatable cell-penetrating peptide, Ceeee[Ahx]PLGLAGrrrrrK, labele

55 Hundreds of sequences now fall within the cell penetrating peptide classification and HIV-Tat, pen

56 Cell-penetrating peptides combined with a dominant negat

57 tidic nanoparticle (NP) platform featuring a cell penetrating peptide complexed to NF-kappaB p65 siRN

58 We designed cell-penetrating peptides comprised of the translocating

59 and synthesis of a BBB-penetrant macrocyclic cell-penetrating peptide conjugate (M13) covalently link

60 eport the synthesis of C-POC, a novel Pt(IV) cell-penetrating peptide conjugate showing a reduced imp

61 Cell-penetrating peptide conjugated peptide aldehydes Ta

62 first report that documents the benefits of cell-penetrating peptide conjugation to enhance the pote

63 Recently, novel cell-penetrating peptide constructs such as HIV-1 TAT ba

64 nsitive nanocarriers, pre forming liposomes, cell penetrating peptide containing systems and virosome

65 Remarkably, a cell-penetrating peptide containing the N-terminal seque

66 Incubation of cultured SMCs with a cell-penetrating peptide containing the N-terminal seque

67 A cell-penetrating peptide containing this sequence compet

68 In this study, a cell penetrating peptide, containing the core HIV-1 Tat

69 ciency of delivering RNPs can be enhanced by cell-penetrating peptides (covalently fused to the prote

70 ear localization sequence (FUSR521G) and the cell-penetrating peptide CP-FUS-NLS that we previously s

71 ne linear bifunctional sequence containing a cell penetrating peptide (CPP) and a nuclear localizatio

72 We have investigated a range of cell penetrating peptide (CPP) conjugates of a 16mer pep

73 s into intact RBCs, which was meditated by a cell penetrating peptide (CPP) developed in our lab-low

74 Among these approaches, cell penetrating peptide (CPP) is promising and affords

75 g of antibodies linked with heparin, and the cell penetrating peptide (CPP) modified drug component.

76 Herein, we report the use of the modified cell penetrating peptide (CPP) platform, Glycosaminoglyc

77 Here, we report an activatable cell penetrating peptide (CPP) strategy ultimately aimed

78 folding framework, and hybridize it with the cell penetrating peptide (CPP) that allows for effective

79 es bearing one or two sequences containing a cell penetrating peptide (CPP), a nuclear localization s

80 ith low molecular weight protamine (LMWP), a cell penetrating peptide (CPP), insulin showed greatly i

81 endosomal leakage domain (ELD), but not the cell penetrating peptide (CPP), was functionally importa

82 Among those strategies, enzyme-triggered cell penetrating peptide (CPP)-mediated systems seem to

83 lf-peptide on DCs through linkage of it to a cell penetrating peptide (CPP).

84 is formed by PEG-PLA chains modified with a cell penetrating peptide (CPP).

85 Cell penetrating peptides (CPP) and cationic antibacteri

86 anelles (AnOs) that exposed surface-attached cell penetrating peptides (CPP) for enhanced uptake and

87 Cell penetrating peptides (CPP) have the ability to rapi

88 action and their ability to be conjugated to cell penetrating peptides (CPP) to overcome challenging

89 Previously, we demonstrated that cell-penetrating peptide (CPP) additives equipped with e

90 The hybrid peptide containing cell-penetrating peptide (CPP) and collagen (COLL) domai

91 review recent advances in clinical trials of cell-penetrating peptide (CPP) applications for immunoth

92 In the current study, we have developed a cell-penetrating peptide (CPP) conjugate of the HIV TAT

93 hich the fluorescently labeled, polycationic cell-penetrating peptide (CPP) is coupled via a cleavabl

94 eractions between traptamers revealed that a cell-penetrating peptide (CPP) on L2 mediates transient

95 ical mediated oligomerization, IAPP acquires cell-penetrating peptide (CPP) properties, facilitating

96 in of HIV-1 TAT, TAT(48-60), is an efficient cell-penetrating peptide (CPP) that diffuses across the

97 R) has been previously identified as a novel cell-penetrating peptide (CPP) that is able to efficient

98 ith low molecular weight protamine (LMWP), a cell-penetrating peptide (CPP) which was shown to effici

99 ntibiotics, while transportan 10 (TP10) is a cell-penetrating peptide (CPP) with anticancer propertie

100 sidues in its structure, could function as a cell-penetrating peptide (CPP), also termed protein tran

101 y with streptavidin (tetramer or monomer), a cell-penetrating peptide (CPP), and an endosomolytic pep

102 ed using recombinant technology to contain a cell-penetrating peptide (CPP), i.e. Model Amphipathic P

103 Although it is a highly competitive cell-penetrating peptide (CPP), its relatively large siz

104 the micelles with a novel and highly potent cell-penetrating peptide (CPP), RMMR1, identified using

105 goarginine peptide R9C, a prototype cationic cell-penetrating peptide (CPP), with planar lipid membra

106 in, we report a simple yet effective system, cell-penetrating peptide (CPP)-assisted poly(lactic-co-g

107 A cell-penetrating peptide (CPP)-morpholino oligonucleotid

108 helical structure of CAI and convert it to a cell-penetrating peptide (CPP).

109 Peptide therapy using cell-penetrating peptides (CPP) as peptide carriers is p

110 ic behavior of molecular transporters of the cell-penetrating-peptide (CPP) type on a biological memb

111 Cell-based delivery of cell penetrating peptides (CPPs) could represent a new p

112 Cell penetrating peptides (CPPs) have attracted recent i

113 Cell penetrating peptides (CPPs) have been extensively s

114 NLCs was modified with six-histidine tagged cell penetrating peptides (CPPs) or YKA.

115 For cell penetrating peptides (CPPs) to fulfil their promise

116 use of EVs as a novel carrier of therapeutic cell penetrating peptides (CPPs).

117 weight:weight) ratio; and (iii) inclusion of cell penetrating peptides (CPPs).

118 the use of synthetically conjugated cationic cell penetrating peptides (CPPs).

119 Cell-penetrating peptides (CPPs) allow intracellular del

120 some overlap in the biological activities of cell-penetrating peptides (CPPs) and antimicrobial pepti

121 emonstrated by polymerizing well-established cell-penetrating peptides (CPPs) and showing that the re

122 luence the delivery of cargoes into cells by cell-penetrating peptides (CPPs) and the bactericidal ac

123 Cationic cell-penetrating peptides (CPPs) are a promising vehicle

124 Although cationic cell-penetrating peptides (CPPs) are able to bind to cel

125 t siCPDs are nontoxic under conditions where cell-penetrating peptides (CPPs) are cytotoxic.

126 Cell-penetrating peptides (CPPs) are promising molecules

127 Arginine-rich cell-penetrating peptides (CPPs) are promising transport

128 Cell-penetrating peptides (CPPs) are short peptide seque

129 Cell-penetrating peptides (CPPs) are small cationic pept

130 Cell-penetrating peptides (CPPs) are well established as

131 Cell-penetrating peptides (CPPs) enter the cell by two d

132 Many cell-penetrating peptides (CPPs) fold at cell surfaces,

133 istry, which increase SMN protein levels, to cell-penetrating peptides (CPPs) for better cellular dis

134 Hundreds of cationic antimicrobial and cell-penetrating peptides (CPPs) form amphipathic alpha-

135 Screening of cell-penetrating peptides (CPPs) fused to CRISPR-Cas9 pr

136 Among the non-viral strategies, cell-penetrating peptides (CPPs) have been a topic of in

137 Cell-penetrating peptides (CPPs) have been studied as th

138 formed by antimicrobial peptides (AMPs) and cell-penetrating peptides (CPPs) in bacterial membranes

139 of this peptide by incorporating a series of cell-penetrating peptides (CPPs) into the DGEA sequence.

140 Cellular association of polyarginine-based, cell-penetrating peptides (CPPs) is effectively blocked

141 coating of these blended particles with the cell-penetrating peptides (CPPs) mTAT, bPrPp and MPG via

142 Cell-penetrating peptides (CPPs) promote the uptake of d

143 Cell-penetrating peptides (CPPs) provide promising tools

144 In this study we have employed cell-penetrating peptides (CPPs) to deliver the ALS-asso

145 that include a small molecule, targeting and cell-penetrating peptides (CPPs), and a large polysaccha

146 ein transduction domains (PTDs), also called cell-penetrating peptides (CPPs), can promote uptake of

147 Like many cell-penetrating peptides (CPPs), CPMPs enter the endocy

148 airpin family of protegrin-1 (PG-1), and two cell-penetrating peptides (CPPs), HIV TAT and penetratin

149 ncy is covalent conjugation of antigens with cell-penetrating peptides (CPPs), linear cationic and am

150 Using cell-penetrating peptides (CPPs), mitochondria were tran

151 Cell-penetrating peptides (CPPs), such as the HIV TAT pe

152 jugation of our reporter system to different cell-penetrating peptides (CPPs), we were able to achiev

153 ieved by covalent attachment to a variety of cell-penetrating peptides (CPPs).

154 al transcription factors (ATFs) are fused to cell-penetrating peptides (CPPs).

155 cytosol and nucleus of cells using trimeric cell-penetrating peptides (CPPs).

156 3-1851) for short sequences that function as cell-penetrating peptides (CPPs).

157 heroids to screen and identify BBB-penetrant cell-penetrating peptides (CPPs).

158 n two new concepts to activate arginine-rich cell-penetrating peptides (CPPs).

159 l or epithelial monolayers is conjugation to cell-penetrating peptides (CPPs); however, very little i

160 ubiquitin and employed a cyclic polyarginine cell-penetrating peptide (cR(10)) conjugated to the N-te

161 jugation of the lead cyclotide to the cyclic cell-penetrating peptide cR10 was the most effective.

162 netic evaluation of a lipid conjugate of the cell-penetrating peptide cyclic nonaarginine, we aimed t

163 n ASO coupled with Pip6a as an arginine-rich cell-penetrating peptide decreased IgE secretion in vivo

164 SynB3 cell-penetrating peptide derivatives were applied that c

165 Here, we investigate DG9, a cell-penetrating peptide derived from human polyhomeotic

166 Conjugation of the cell-penetrating peptide derived from the human immunode

167 this cell line was resistant to uptake of a cell-penetrating peptide derived from the TAT protein.

168 Herein, we demonstrate how a novel cell-penetrating peptide disruptor (DRx-170) of the c-RA

169 Guanidinium-rich molecules, such as cell-penetrating peptides, efficiently enter living cell

170 Using an activatable cell-penetrating peptide engineered to detect thrombin a

171 acellular compartment by conjugating it to a cell-penetrating peptide for active transport.

172 Indeed, current methods (using cell-penetrating peptides for instance) provide very low

173 n the much smaller TAT peptide, the original cell-penetrating peptide from HIV.

174 anuclear epitopes using antibodies tagged to cell-penetrating peptides has great potential given its

175 us TAT protein transduction domain (PTD), or cell-penetrating peptide, has previously been surmised t

176 payloads into the cytosolic space of cells, cell-penetrating peptides have to cross biological membr

177 Covalent attachment of a cell-penetrating peptide helps to improve cell delivery

178 We have developed an AAC-11-derived cell-penetrating peptide, herein named RT53, mimicking i

179 Cell penetrating peptides hold considerable potential fo

180 Cell-penetrating peptides, hydrogels, polymer-based nano

181 GFR-specific GE11 peptide), acid-activatable cell-penetrating peptides (i.e., TH peptide), and imagin

182 Our results showed that P12 acted like some cell-penetrating peptides in that it redirected ligand-b

183 -exchange studies in solution, activation of cell-penetrating peptides in vesicles, and computational

184 six different antimicrobial, cytolytic, and cell-penetrating peptides, including some of their varia

185 Antimicrobial, cytolytic, and cell-penetrating peptides induce pores or perturbations

186 Targeting MUC1-C with the cell-penetrating peptide inhibitor GO-203 disrupts MUC1-

187 M cells, and targeting MUC1-C with GO-203, a cell-penetrating peptide inhibitor of MUC1-C homodimeriz

188 ore and Rosbash discuss a new strategy using cell-penetrating peptide inhibitors for unraveling the r

189 Cell-penetrating peptide inhibitors of the MUC1-C subuni

190 ADSL-Beclin1 axis by knock-in mutation or a cell-penetrating peptide inhibits autophagy induced by l

191 human serum albumin (HSA) equipped with the cell-penetrating peptide iRGD.

192 To access targets within cells, a cyclic cell-penetrating peptide is appended to DNA-encoded libr

193 ctivating transcriptional activator (TAT), a cell-penetrating peptide, is extensively used for facili

194 -activated protein kinase 2 (MK2)-inhibiting cell-penetrating peptide (KAFAK).

195 blems by mucoadhesive NPs (MNPs) loaded with cell penetrating peptide-linked insulin conjugates.

196 For example, a probe with cell-penetrating peptide loops targets the surface of ce

197 This proof-of-concept cell-penetrating peptide may aid validation of capsid as

198 Cell-penetrating peptide-mediated delivery of phosphorod

199 GFP protein either by electroporation or by cell-penetrating peptide-mediated import leads to format

200 A competing cell-penetrating peptide mimetic derived from the Na(V)1

201 d of a hydrophilic guanidine-rich block as a cell-penetrating peptide mimic, and a rigid organic semi

202 dings relating to experimental protocols and cell penetrating peptide modifications or extensions tha

203 A cell-penetrating peptide-modified fusogenic liposomal me

204 ich can be internalized via conjugation with cell-penetrating peptide moieties; and Cas9 ribonucleopr

205 ed delivery, previous studies have relied on cell penetrating peptides, nanoparticles or specific bio

206 necessary for EN1 function and an N-terminal cell-penetrating peptide/nuclear localization sequence.

207 p28 is an anionic cell-penetrating peptide of 28 amino acids that activate

208 Here, we investigate the effect of cell-penetrating peptides on the biological activity of

209 rational design of AAV9 variants displaying cell-penetrating peptides on the viral capsid and the id

210 e PNA to another large molecule, typically a cell-penetrating peptide or nanoparticle.

211 Linking ASOs to cell-penetrating peptides, or even other moieties, is an

212 in size when mixed with cationic amphipathic cell-penetrating peptide (p5RHH).

213 aggregating peptide (p216), derived from the cell-penetrating peptide penetratin, which showed 12-fol

214 The interaction between the cell-penetrating peptide, penetratin, and solid-supporte

215 The membrane-bound conformation of a cell-penetrating peptide, penetratin, is investigated us

216 Applying this method to a cell-penetrating peptide, penetratin, we found that at l

217 ion of scFvs, we investigated the utility of cell-penetrating peptides, penetratin and transactivator

218 Tf) for receptor mediated transcytosis and a cell penetrating peptide-penetratin (Pen) for enhanced c

219 eral tumor cells only when it was fused to a cell-penetrating peptide (pep5-cpp), suggesting its intr

220 Using a cell-penetrating peptide (pepducin) approach, we provide

221 Cell-penetrating peptide PepFect6 (PF6) has been shown t

222 These data may also explain variability in cell-penetrating peptide performance in different experi

223 This study demonstrates that the cell penetrating peptide-photosensitiser bioconjugation

224 hat conjugating an ASO with an arginine-rich cell-penetrating peptide, Pip6a, enhanced delivery, resu

225 iamidate morpholino oligomer with a designed cell-penetrating peptide (PPMO) targeting a mutated dyst

226 Fusion of cyclic peptides with a cyclic cell-penetrating peptide produces bicyclic peptides that

227 ed that brush polymer formulations utilizing cell penetrating peptides promoted Cre delivery but olig

228 ral elements of ApoB-100 indicate it to have cell-penetrating peptide properties.

229 The cell-penetrating peptide R8 endows HUNGER deep tumor pen

230 ed in real time with ratiometric activatable cell penetrating peptides (RACPPs).

231 s, for the first time, that the amphipathic, cell-penetrating peptide RALA can efficiently deliver mi

232 acilitated complexation with the amphipathic cell-penetrating peptide RALA to produce nanoparticles (

233 We designed two new cell-penetrating peptides - RB1 and RB3 - that penetrate

234 Here we show that a cell-penetrating peptide, ReACp53, designed to inhibit p

235 tic proteins interaction and, if linked to a cell-penetrating peptide, reduces glutamate release in a

236 ts into a novel disulfide-rich, anionic, and cell-penetrating peptide, representing a potential lead

237 Conjugation to a cell-penetrating peptide resulted in inhibitors that ind

238 nctional filaggrin (FLG) monomer linked to a cell-penetrating peptide (RMR) and to test the ability o

239 study, we demonstrate that an arginine-rich cell-penetrating peptide, (RXRRBR)(2)XB, dramatically im

240 Htt(NT) derivatives with C-terminal cell-penetrating peptide segments also exhibit excellent

241 we designed a competitive peptide fused to a cell penetrating peptide sequence, which displayed effic

242 quence of HPV L2 protein, which overlaps its cell-penetrating peptide sequence, binds IPO7 directly i

243 croparticles with a fluorophore as well as a cell-penetrating peptide sequence, which facilitated the

244 These attributes suggest that related, cell-penetrating peptides should effectively inhibit act

245 Tp10 is a 21-residue, amphipathic, cationic, cell-penetrating peptide similar to helical antimicrobia

246 nhibit miRNA function using vehicles such as cell penetrating peptides, spherical nucleic acids, defo

247 from that of the well-known, highly cationic cell penetrating peptides such as the tat peptide from H

248 behavior of the well-known, highly cationic cell-penetrating peptides, such as the HIV tat peptide,

249 elivery of genes, oligonucleotide therapies, cell-penetrating peptides, synthetic transcription facto

250 ely delivered to tumors using an activatable cell-penetrating peptide targeting matrix metalloprotein

251 t nanoparticle surface modification with the cell penetrating peptide TAT facilitates brain-specific

252 njugates (NTD, d-NTD and q-NTD) in which the cell penetrating peptide Tat is covalently connected to

253 The cell-penetrating peptide Tat (GRKKRRQRRRPPQGYG) was also

254 promoted azide-alkyne cycloaddition with the cell-penetrating peptide TAT (GRKKRRQRRRPPQGYG), which a

255 ve HA2 fusion peptide from influenza and the cell-penetrating peptide TAT from HIV.

256 rface modification of nanoparticles with the cell-penetrating peptide TAT increases their biophysical

257 a tetramethylrhodamine-labeled dimer of the cell-penetrating peptide TAT, dfTAT, penetrates live cel

258 se 2 (MMP2)-sensitive peptide linker (pp), a cell penetrating peptide (TAT), and a model drug (doxoru

259 ) (PLGA) nanoparticles (NPs) conjugated to a cell-penetrating peptide, TAT, was used to increase intr

260 Here, a cell-penetrating peptide, termed a pepducin, circumvents

261 Here, we demonstrate the utility of novel cell-penetrating peptides, termed 'pepducins', that act

262 ating properties of a conserved human origin cell penetrating peptide that may be harnessed as a nove

263 The linkers are cell compatible; a cell-penetrating peptide that contained this linker was

264 We have developed a cell-penetrating peptide that disrupts homodimerization

265 Finally, a cell-penetrating peptide that inhibits FUS nuclear trans

266 combinant protein is fused with Z12, a novel cell-penetrating peptide that promotes efficient protein

267 Pep-1 is a cell-penetrating peptide that represents a powerful stra

268 A cell-penetrating peptide that specifically blocks MRE11

269 ystem, and an engineered melanin binding and cell-penetrating peptide that sustains intraocular drug

270 Cell-penetrating peptides that block the WSTF-ATG8 inter

271 ng fundamentally from the positively charged cell-penetrating peptides, the biocompatibility, stabili

272 oligohistidine affinity tags to function as cell-penetrating peptides, this metal-chelating cell sur

273 the N-terminus with fluorescein and a cyclic cell-penetrating peptide through native chemical ligatio

274 etics of the translocation of arginine-rich, cell-penetrating peptides through membranes are still un

275 mphiphilic polymer functionalized with tumor cell penetrating peptide to accommodate lipophilic small

276 Conjugating cell penetrating peptides to the compact ligand coated Q

277 ighly cell-permeable by conjugating a cyclic cell-penetrating peptide to their N-terminus, C-terminus

278 the polymer-coated QDs have been coupled to cell-penetrating peptides to facilitate intracellular up

279 Conjugation of cell-penetrating peptides to the stapled peptide resulte

280 e efficiencies with which three families of "cell-penetrating peptides" traffic to the cytosol of mam

281 as sites of cell-surface interaction for the cell-penetrating peptide trans-activator of transcriptio

282 ed anti-gammaH2AX antibody conjugated to the cell-penetrating peptide transactivator of transcription

283 The mechanism of the interaction between the cell-penetrating peptide transportan 10 (tp10) and phosp

284 ic model that we previously proposed for the cell-penetrating peptide transportan 10 (tp10), but with

285 oxacin (CIP) or levofloxacin (LVX), with the cell-penetrating peptide transportan 10 (TP10).

286 NAs transported into cortical neurons by the cell-penetrating peptide transportan 10.

287 osed for PCI by conjugating the chlorin to a cell penetrating peptide, using bioorthogonal ligation c

288 e antiviral activity, but when a Tat-derived cell-penetrating peptide was appended, the resulting mol

289 A hydrogen peroxide (H2O2)-activated cell-penetrating peptide was developed through incorpora

290 uction properties of two basic arginine-rich cell penetrating peptides, we demonstrate widespread sys

291 beta-arrestin signaling process with a novel cell-penetrating peptide, we were able to inhibit both t

292 ation of conditional knockout (cKO) mice and cell-penetrating peptides, we show that GIV (CCDC88A), a

293 other cationic molecules are widely used as cell-penetrating peptides, we studied several cationic p

294 membrane helices 5 and 6 of CB1R, fused to a cell-penetrating peptide, were able to disrupt receptor

295 membrane and, when conjugated to a cationic cell-penetrating peptide, were indiscriminately cytotoxi

296 rg9-TAMRA, a representative highly cationic, cell-penetrating peptide, which entered cells only when

297 rt a family of novel ratiometric activatable cell-penetrating peptides, which contain Cy5 as far red

298 ptionally stable and highly efficient cyclic cell penetrating peptide whose sequence is derived from

299 We characterize S100A1ct as a cell-penetrating peptide with positive inotropic and ant